Skip Navigation

Women Health Segment: Progress on DCP Submission

15 September 2022

One of our key targets is to deliver a diversified and competitive portfolio and support our partners in every step of their journey.

In this respect, we are pleased to announce that we have submitted several DCPs and national applications for a number of products within our women health portfolio. Our intention is to assist our partners with the different challenges that mature products may present.

Adalvo has embarked on a strategic collaboration with a partner that specializes in this domain and is offering a basket of hormonal products, that will enable our partners to offer a wide array of oral contraceptive and hormonal replacement products, at a global level.

Disclaimer: Products which are subject to patent protection are currently not offered or made available in countries where patents are in force.